title: Daily variations of the involvement of beta-receptors in the sympathetic nerve action on glycogenolysis in perfused rat liver.
abstract: In perfused rat liver perivascular nerve stimulation (7.5 Hz, 20 V, 2 ms, 5 min) at the liver hilus caused an increase in glucose release, a shift of lactate uptake to output and a decrease in arterial, portal and total flow. The influence of the alpha 1-receptor blocker prazosin and the beta-antagonist propranolol on these nerve effects were studied in the isolated rat liver perfused via both the hepatic artery and the portal vein in three experimental series at 9 a.m., at 2 p.m. and at 8 p.m. 1) The nerve stimulation-dependent increase in glucose output was maximal at 9 a.m. (100%), halfmaximal at 2 p.m. (50%) and very low at 8 p.m. (15%). The alterations in arterial, portal and total flow were similar in all three series. 2) At 9 a.m., at 2 p.m. and at 8 p.m. 5 microM arterial plus portal prazosin nearly completely inhibited the metabolic alterations and blocked the reduction of arterial, portal and total flow by 80%. 3) At 9 a.m. 10 microM arterial, portal and arterial plus portal propranolol inhibited the increase in glucose release to less than 25% and the shift of lactate uptake to output to about 50%. At 2 p.m. this inhibitory effect was not observed, neither by selective arterial or portal, nor by simultaneous arterial plus portal addition of 10 microM propranolol. At 8 p.m. the influence of propranolol could not be studied because of the too small control values. The nerve stimulation-dependent reduction of arterial, portal and total flow was not influenced by propranolol, neither at 9 a.m. nor at 2 p.m.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institut für Biochemie, Fachbereich Medizin, Universität, Göttingen.
authors.forename: A
authors.initials: A
authors.lastname: Gardemann
authors.forename: H
authors.initials: H
authors.lastname: Beck
authors.forename: K
authors.initials: K
authors.lastname: Jungermann
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002940:Circadian Rhythm / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D008099:Liver / Q000098:blood supply / Q000187:drug effects / Q000294:innervation*; D008102:Liver Circulation / Q000187:drug effects; D008112:Liver Glycogen / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010477:Perfusion; D011224:Prazosin / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D015398:Signal Transduction; D013564:Sympathetic Nervous System / Q000098:blood supply / Q000187:drug effects / Q000502:physiology*
chemical_list: D001786:Blood Glucose; D007773:Lactates; D008112:Liver Glycogen; D011943:Receptors, Adrenergic, beta; D019344:Lactic Acid; D011433:Propranolol; D011224:Prazosin